Differences between exogenous and endogenous noradrenaline in the effects on vascular post-synaptic alpha 1- and alpha 2-adrenoceptors in man
- PMID: 2856814
Differences between exogenous and endogenous noradrenaline in the effects on vascular post-synaptic alpha 1- and alpha 2-adrenoceptors in man
Abstract
Effects of exogenous and endogenous noradrenaline, released by tyramine and lower body negative pressure (LBNP), on vascular post-synaptic alpha 1- and alpha 2-adrenoceptors have been compared in healthy volunteers. Intra-arterial (i.a.) infusions of noradrenaline and tyramine into the forearm were given in the presence of saline, of yohimbine and of doxazosin, and changes in forearm blood flow (FBF) were measured. Lower body negative pressure of -40 mmHg was applied without and with a continuous i.a. infusion of yohimbine and of doxazosin, and changes in FBF in both forearms were compared. Forearm blood flow was measured by venous occlusion plethysmography. Noradrenaline and tyramine reduced FBF dose-dependently and to the same extent. Both these vasoconstrictions were significantly reduced by yohimbine (P < 0.001 for both) as well as by doxazosin (P < 0.05 for noradrenaline and P < 0.001 for tyramine). The tyramine-induced vasoconstriction was more effectively reduced by doxazosin, whereas yohimbine reduced the noradrenaline-induced vasoconstriction more effectively. Lower body negative pressure reduced FBF in both forearms to the same extent. Doxazosin effectively inhibited the LBNP induced decrease in FBF (P < 0.05) whereas yohimbine had no effect (P > 0.05). These results are in accordance with a predominant intrasynaptic location of post-synaptic alpha 1-adrenoceptors and a predominant extrasynaptic location of post-synaptic alpha 2-adrenoceptors in human blood vessels.
Similar articles
-
Effects of exogenous adrenaline and noradrenaline on vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man.J Hypertens Suppl. 1984 Dec;2(3):S119-21. J Hypertens Suppl. 1984. PMID: 6100733
-
Postsynaptic alpha 1- and alpha 2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines.Eur J Clin Invest. 1987 Apr;17(2):174-81. doi: 10.1111/j.1365-2362.1987.tb02397.x. Eur J Clin Invest. 1987. PMID: 3034621 Clinical Trial.
-
Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans.J Cardiovasc Pharmacol. 1987 Apr;9(4):407-13. doi: 10.1097/00005344-198704000-00005. J Cardiovasc Pharmacol. 1987. PMID: 2438503
-
Vascular alpha-adrenoceptors in man: interactions with adrenaline and noradrenaline.Clin Sci (Lond). 1985;68 Suppl 10:151s-153s. doi: 10.1042/cs068s151. Clin Sci (Lond). 1985. PMID: 2982538 Clinical Trial.
-
alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs.J Med Chem. 1982 Dec;25(12):1389-401. doi: 10.1021/jm00354a001. J Med Chem. 1982. PMID: 6296387 Review. No abstract available.
Cited by
-
Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.Drugs. 1988 May;35(5):525-41. doi: 10.2165/00003495-198835050-00003. Drugs. 1988. PMID: 2899495 Review.
-
Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle?J Physiol. 2002 Jun 1;541(Pt 2):623-35. doi: 10.1113/jphysiol.2001.014431. J Physiol. 2002. PMID: 12042366 Free PMC article. Clinical Trial.
-
Diminished baroreflex-induced vasoconstriction following alpha-2 adrenergic receptor blockade in humans.Auton Neurosci. 2008 Feb 29;138(1-2):114-7. doi: 10.1016/j.autneu.2007.11.002. Epub 2007 Dec 4. Auton Neurosci. 2008. PMID: 18054844 Free PMC article.